|
1000
|
Abstract/Summary
|
-
This study took place in November 2021 and aimed to determine the frequency and nature of significant health events among pregnant females after COVID-19 vaccination, compared with unvaccinated pregnant controls and vaccinated non-pregnant individuals. The working group set up an observational cohort study, set in seven Canadian provinces and territories. More than 1 million pregnant and non-pregnant females aged 15-49 years were enrolled as study participants. Data were collected primarily by self-reported survey after both vaccine doses, with telephone follow-up for those reporting any medically attended event. In this webinar, the results of the study will be presented, which give answer to the question if COVID-19 mRNA vaccines have a good safety profile in pregnancy and can be recommended. The speakers will also introduce the Canadian Vaccine Safety Network (CANVAS), which in addition to monitoring the seasonal influenza vaccine safety, monitors vaccine safety for other and new vaccines, and provides a platform for vaccine acceptability studies.
|
